APPLICATION
ANDA076000
TYPE
ANDA
ORIGINAL APPROVAL
2011-10-24
LATEST ACTION
2015-04-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
OLANZAPINEDiscontinued
OLANZAPINE 10MG · TABLET · ORAL
OLANZAPINEDiscontinued
OLANZAPINE 5MG · TABLET · ORAL
OLANZAPINEDiscontinued
OLANZAPINE 15MG · TABLET · ORAL
OLANZAPINEDiscontinued
OLANZAPINE 7.5MG · TABLET · ORAL
OLANZAPINEDiscontinued
OLANZAPINE 2.5MG · TABLET · ORAL
Approval history
2015-04-15Labeling · Supplement 5 · standardAP
2015-01-16Labeling · Supplement 3 · standardAP
2011-10-24OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.